TARSUS PHARMACEUTICALS, INC. (TARS) Net income 2018–2025
TARSUS PHARMACEUTICALS, INC. (TARS) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$66.4MFY2025 · since FY2018: -$1.3M → -$66.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$66.4M | +42.5% |
| FY2024 | -$115.6M | +15.0% |
| FY2023 | -$135.9M | -118.9% |
| FY2022 | -$62.1M | -349.1% |
| FY2021 | -$13.8M | +48.4% |
| FY2020 | -$26.8M | -474.1% |
| FY2019 | -$4.7M | -254.1% |
| FY2018 | -$1.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TARS financial trends
TARS RevenueTARS Net marginTARS Gross profitTARS Gross marginTARS Operating incomeTARS Operating marginTARS Operating cash flowTARS Free cash flowTARS Capital expendituresTARS Return on equityTARS Stock buybacksTARS Dividends paidTARS Total assetsTARS Total liabilitiesTARS Shareholders’ equityTARS overview →